Overview
The aim of this study is to perform, in real world clinical practice, a three-dimensional assessment from patient's, caregiver's and physician's perspectives, of the impact of AboBoNT-A on caregiver burden, functional disability and other health care measures in patients affected with ULS due to acquired brain injuries.
Eligibility
Inclusion Criteria:
- The patient is able to comply with the protocol;
- Male and female patients who are at least 18 years old;
- The patient is supported by an identified caregiver (family member or other nonpaid
adult
- if the patient has more than one caregiver, the main caregiver will be selected) who provides daily supervision or direct assistance to the care recipient;
- The patient has been diagnosed with ULS due to non-progressive acquired brain injuries
(stroke, traumatic brain injury, surgical resection of non-progressive tumours, other);
- The decision to treat the patient with AboBoNT-A by the care provider will be made prior to, and independently from the decision to enrol the patient in the observational study;
- The patient is covered by a healthcare insurance;
- The cognitive and health status of the patient is compatible with the participation to the study.
Exclusion Criteria:
- Contraindication to BoNT-A treatment;
- Previously treated with BoNT-A in upper limbs within the last 12 months;
- Patients who are opposed to their data collection;
- Caregivers who are opposed to their data collection;
- Caregivers already included for another patient;
- Current participation in any other interventional clinical study or have participated within the 12 weeks prior to the inclusion visit;
- Non-ambulatory patients except for patients hospitalized for injection (maximum 48 hours) and day hospitalizations;
- Vulnerable patients (i.e. pregnant and/or lactating women, children, patient under curatorship or deprived of liberty).